LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: The signal peptide as a new target for drug design.

    Lumangtad, Liezel A / Bell, Thomas W

    Bioorganic & medicinal chemistry letters

    2020  Volume 30, Issue 10, Page(s) 127115

    Abstract: Many current and potential drug targets are membrane-bound or secreted proteins that are expressed and transported via the Sec61 secretory pathway. They are targeted to translocon channels across the membrane of the endoplasmic reticulum (ER) by signal ... ...

    Abstract Many current and potential drug targets are membrane-bound or secreted proteins that are expressed and transported via the Sec61 secretory pathway. They are targeted to translocon channels across the membrane of the endoplasmic reticulum (ER) by signal peptides (SPs), which are temporary structures on the N-termini of their nascent chains. During translation, such proteins enter the lumen and membrane of the ER by a process known as co-translational translocation. Small molecules have been found that interfere with this process, decreasing protein expression by recognizing the unique structures of the SPs of particular proteins. The SP may thus become a validated target for designing drugs for numerous disorders, including certain hereditary diseases.
    MeSH term(s) Adaptor Proteins, Vesicular Transport/genetics ; Adaptor Proteins, Vesicular Transport/metabolism ; CD4 Antigens/genetics ; CD4 Antigens/metabolism ; Drug Design ; Endoplasmic Reticulum/metabolism ; Humans ; Protein Sorting Signals/drug effects ; Protein Transport/drug effects ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology
    Chemical Substances Adaptor Proteins, Vesicular Transport ; CD4 Antigens ; Protein Sorting Signals ; Small Molecule Libraries ; sortilin (Z020Y8WIJ4)
    Keywords covid19
    Language English
    Publishing date 2020-03-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2020.127115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.

    Lumangtad, Liezel A / Claeys, Elisa / Hamal, Sunil / Intasiri, Amarawan / Basrai, Courtney / Yen-Pon, Expedite / Beenfeldt, Davison / Vermeire, Kurt / Bell, Thomas W

    Bioorganic & medicinal chemistry

    2020  Volume 28, Issue 24, Page(s) 115816

    Abstract: CADA compounds selectively down-modulate human cell-surface CD4 protein and are of interest as HIV entry inhibitors and as drugs for asthma, rheumatoid arthritis, diabetes and some cancers. Postulating that fusing a pyridine ring bearing hydrophobic ... ...

    Abstract CADA compounds selectively down-modulate human cell-surface CD4 protein and are of interest as HIV entry inhibitors and as drugs for asthma, rheumatoid arthritis, diabetes and some cancers. Postulating that fusing a pyridine ring bearing hydrophobic substituents into the macrocyclic scaffold of CADA compounds may lead to potent compounds with improved properties, 17 macrocycles were synthesized, 14 with 12-membered rings having an isobutylene head group, two arenesulfonyl side arms, and fused pyridine rings bearing a para substituent. The analogs display a wide range of CD4 down-modulating and anti-HIV potencies, including some with greater potency than CADA, proving that a highly basic nitrogen atom in the 12-membered ring is not required for potency and that hydrophobic substituents enhance potency of pyridine-fused CADA compounds. Cytotoxicities of the new compounds compared favorably with those of CADA, showing that incorporation of a pyridine ring into the macrocyclic scaffold can produce selective compounds for potently down-modulating proteins of medicinal interest.
    MeSH term(s) Animals ; Anti-HIV Agents/chemical synthesis ; Anti-HIV Agents/chemistry ; Anti-HIV Agents/pharmacology ; CD4 Antigens/genetics ; CD4 Antigens/metabolism ; CHO Cells ; Cell Line ; Cell Survival/drug effects ; Cricetinae ; Cricetulus ; Down-Regulation/drug effects ; HIV-1/metabolism ; Heterocyclic Compounds/chemical synthesis ; Heterocyclic Compounds/chemistry ; Heterocyclic Compounds/pharmacology ; Humans ; Pyridines/chemistry ; Solubility ; Structure-Activity Relationship ; Sulfonamides/chemical synthesis ; Sulfonamides/chemistry ; Sulfonamides/pharmacology ; Thermodynamics ; Virus Replication/drug effects
    Chemical Substances Anti-HIV Agents ; CD4 Antigens ; Heterocyclic Compounds ; Pyridines ; Sulfonamides ; pyridine (NH9L3PP67S)
    Language English
    Publishing date 2020-10-26
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1161284-8
    ISSN 1464-3391 ; 0968-0896
    ISSN (online) 1464-3391
    ISSN 0968-0896
    DOI 10.1016/j.bmc.2020.115816
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.

    Berger, Karoline / Pauwels, Eva / Parkinson, Gabrielle / Landberg, Göran / Le, Truc / Demillo, Violeta G / Lumangtad, Liezel A / Jones, Dylan E / Islam, Md Azizul / Olsen, Ryan / Kapri, Topprasad / Intasiri, Amarawan / Vermeire, Kurt / Rhost, Sara / Bell, Thomas W

    Journal of medicinal chemistry

    2021  Volume 64, Issue 17, Page(s) 12865–12876

    Abstract: Cyclotriazadisulfonamide (CADA) compounds selectively down-modulate two human proteins of potential therapeutic interest, cluster of differentiation 4 (CD4) and sortilin. Progranulin is secreted from some breast cancer cells, causing dedifferentiation of ...

    Abstract Cyclotriazadisulfonamide (CADA) compounds selectively down-modulate two human proteins of potential therapeutic interest, cluster of differentiation 4 (CD4) and sortilin. Progranulin is secreted from some breast cancer cells, causing dedifferentiation of receiving cancer cells and cancer stem cell proliferation. Inhibition of progranulin binding to sortilin, its main receptor, can block progranulin-induced metastatic breast cancer using a triple-negative in vivo xenograft model. In the current study, seven CADA compounds (CADA, VGD020, VGD071, TL020, TL023, LAL014, and DJ010) were examined for reduction of cellular sortilin expression and progranulin-induced breast cancer stem cell propagation. In addition, inhibition of progranulin-induced mammosphere formation was examined and found to be most significant for TL020, TL023, VGD071, and LAL014. Full experimental details are given for the synthesis and characterization of the four new compounds (TL020, TL023, VGD071, and DJ010). Comparison of solubilities, potencies, and cytotoxicities identified VGD071 as a promising candidate for future studies using mouse breast cancer models.
    MeSH term(s) Adaptor Proteins, Vesicular Transport/metabolism ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Breast Neoplasms ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Drug Delivery Systems ; Drug Discovery ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Neoplastic Stem Cells/drug effects ; Progranulins/pharmacology ; Sulfonamides/chemistry ; Sulfonamides/pharmacology
    Chemical Substances Adaptor Proteins, Vesicular Transport ; Antineoplastic Agents ; Progranulins ; Sulfonamides ; sortilin (Z020Y8WIJ4)
    Language English
    Publishing date 2021-08-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c00943
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Tsuji-Trost Cyclization of Disulfonamides: Synthesis of 12-Membered, 11-Membered, and Pyridine-Fused Macrocyclic Triamines.

    Ali, Rameez / Anugu, Sreenivasa / Chawla, Reena / Demillo, Violeta G / Goulinet-Mateo, Florian / Gyawali, Sagar / Hamal, Sunil / Jones, Dylan E / Lamprecht, Katrin / Le, Truc / Lumangtad, Liezel A / Pflug, Nicholas C / Sama, Alekhya / Scarbrough, Emily D / Bell, Thomas W

    ACS omega

    2019  Volume 4, Issue 1, Page(s) 1254–1264

    Abstract: Macrocyclic triamine disulfonamides can be synthesized by double Tsuji- ... ...

    Abstract Macrocyclic triamine disulfonamides can be synthesized by double Tsuji-Trost
    Language English
    Publishing date 2019-01-15
    Publishing country United States
    Document type Journal Article
    ISSN 2470-1343
    ISSN 2470-1343
    DOI 10.1021/acsomega.8b02555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Tsuji–Trost Cyclization of Disulfonamides

    Rameez Ali / Sreenivasa Anugu / Reena Chawla / Violeta G. Demillo / Florian Goulinet-Mateo / Sagar Gyawali / Sunil Hamal / Dylan E. Jones / Katrin Lamprecht / Truc Le / Liezel A. Lumangtad / Nicholas C. Pflug / Alekhya Sama / Emily D. Scarbrough / Thomas W. Bell

    ACS Omega, Vol 4, Iss 1, Pp 1254-

    Synthesis of 12-Membered, 11-Membered, and Pyridine-Fused Macrocyclic Triamines

    2019  Volume 1264

    Keywords Chemistry ; QD1-999
    Language English
    Publishing date 2019-01-01T00:00:00Z
    Publisher American Chemical Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top